This article delves into the critical need for reform in public spending...
Fundamentals for Apollo Hospitals Enterprise Limited
Last Updated:
2025-10-16 19:31
Overall Fundamental outlook
Business Operations:
Sector: Healthcare Industry: Medical Care Facilities
Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.
Revenue projections:
Revenue projections for APOLLOHOSP Investors may react cautiously to news that APOLLOHOSP's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.
Financial Ratios:
currentRatio
0.00000
forwardPE
45.10072
debtToEquity
90.88600
earningsGrowth
0.41800
revenueGrowth
0.14900
grossMargins
0.33824
operatingMargins
0.10907
trailingEps
109.40000
forwardEps
81.60000
Apollo Hospitals Enterprise Limited's elevated debt-to-equity ratio highlights its heavy reliance on debt. This high leverage increases the company's exposure to financial risk, making it more vulnerable to market fluctuations and economic downturns. APOLLOHOSP's positive earnings and revenue growth signal that the company is expected to expand its business. The company's increasing profits and sales reflect strong financial health, suggesting continued growth and success in the coming periods. Apollo Hospitals Enterprise Limited's lower forward EPS compared to its trailing EPS indicates that the company may be less profitable in the upcoming year. This suggests a potential slowdown in earnings, which could be a sign of weaker financial performance ahead.
Price projections:
Price projections for APOLLOHOSP Apollo Hospitals Enterprise Limited's price has often been near the lower end of the projected range. This ongoing trend suggests that investor confidence might be waning, and the stock could face challenges in gaining upward momentum.
Insider Transactions:
Insider Transactions for APOLLOHOSP
3 transactions to buy APOLLOHOSP shares were recorded, with market price at 6553.183268229167.During the period under consideration, no buy transactions took place.Apollo Hospitals Enterprise Limited's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.
Recommendation changes over time:
Recommendations trend for APOLLOHOSP
Recent analysis shows a strong buy bias for APOLLOHOSP, encouraging investors to view it as a solid investment option. The positive sentiment surrounding APOLLOHOSP suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth look at the UK’s Q2 2025 GDP release by ONS,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.